Drug therapy in brain ischaemia.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000777:Anesthetics / Q000627:therapeutic use; D000818:Animals; D000927:Anticonvulsants / Q000627:therapeutic use; D002545:Brain Ischemia / Q000188:drug therapy*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D004121:Dimethyl Sulfoxide / Q000627:therapeutic use; D004338:Drug Combinations / Q000627:therapeutic use; D011464:Epoprostenol / Q000627:therapeutic use; D005466:Fluorocarbons / Q000627:therapeutic use; D005609:Free Radicals; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives; D007213:Indomethacin / Q000627:therapeutic use; D009270:Naloxone / Q000627:therapeutic use; D011453:Prostaglandins / Q000627:therapeutic use; D013300:Streptokinase / Q000627:therapeutic use; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000777:Anesthetics; D000927:Anticonvulsants; D002121:Calcium Channel Blockers; D004338:Drug Combinations; D005466:Fluorocarbons; D005609:Free Radicals; D006895:Hydroxyethyl Starch Derivatives; D011453:Prostaglandins; D014662:Vasoconstrictor Agents; D009270:Naloxone; C017323:glucose, glycerol, hydroxyethyl starch, perfluorodecalin, perfluorotripropylamine, pluronic F-68, salts, yolk phospholipids drug combination; D006493:Heparin; D011464:Epoprostenol; D013300:Streptokinase; D007213:Indomethacin; D004121:Dimethyl Sulfoxide